Literature DB >> 30731002

Correction: Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait.

.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0203033.].

Entities:  

Year:  2019        PMID: 30731002      PMCID: PMC6366699          DOI: 10.1371/journal.pone.0212118

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


In Table 3, the Total Frequency of respondents who answered Disagree to perception item 1–5 is partially missing. Additionally in Table 4, the Total Frequency of respondents who answered Disagree to perception item 1–3 is partially missing. There are minor formatting errors in Table 5. Please see the corrected Tables 3–5 here. The publisher apologizes for the errors.
Table 3

Respondents’ perceptions towards pharmacogenetics and its implications (n = 617).

Responses the perception itemsPharmacists(n = 238)Frequency (%)Physicians(n = 379)Frequency (%)Total(n = 617)Frequency (%)P value
1. Pharmacogenetics is relevant to my current clinical practice.
Agree164 (69.0)240 (63.3)404 (65.5)0.027*
Neutral55 (23.0)121 (32.0)176 (28.5)
Disagree19 (8.0)18 (4.7)37 (6.0)
2. Pharmacists should be required to have some knowledge of pharmacogenetics.
Agree214 (90.0)326 (86.0)540 (87.5)0.303
Neutral19 (8.0)45 (12.0)64 (10.4)
Disagree5 (2.0)8 (2.0)13 (2.1)
3. Pharmacogenetic testing should be applied into my clinical practice.
Agree180 (75.6)230 (60.7)410 (66.5)<0.001*
Neutral50 (21.0)137 (36.1)187 (30.3)
Disagree8 (3.4)12 (3.2)20 (3.2)
4. Pharmacists should be asked by healthcare professionals for recommendations on appropriate use of pharmacogenetic testing.
Agree162 (68.1)259 (68.3)421 (68.2)0.923
Neutral63 (26.5)102 (27.0)165 (26.7)
Disagree13 (5.5)18 (4.7)31 (5.0)
5. I should be able to provide information on appropriate use of pharmacogenetic testing.
Agree177 (74.4)224 (59.1)401 (65.0)<0.001*
Neutral43 (18.1)137 (36.1)180 (29.2)
Disagree18 (7.6)18 (4.7)36 (5.8)
6. Pharmacogenetics will improve our ability to more effectively control drug therapy expenditures.
Agree184 (77.3)225 (59.4)409 (66.3)<0.001*
Neutral40 (16.8)131 (34.6)171 (27.7)
Disagree14 (5.9)23 (6.1)37 (6.0)

*Significant difference between physicians and pharmacists using Chi-square test

Table 4

Respondents’ confidence in applying pharmacogenetics in their practice settings (n = 617).

Responses to the self-confidence itemsPharmacists(n = 238)Frequency (%)Physicians(n = 379)Frequency (%)Total(n = 617)Frequency (%)P value
1. I can identify drugs that need pharmacogenetic testing.
Agree59 (24.8)86 (22.7)145 (23.5)0.765
Neutral104 (43.7)176 (46.4)280 (45.4)
Disagree75 (31.5)117 (30.9)192 (31.1)
2. I can identify reliable sources of information regarding pharmacogenetics for healthcare professionals and patients.
Agree96 (40.3)102 (26.9)198 (32.1)0.002*
Neutral85 (35.7)166 (43.8)251 (40.7)
Disagree57 (23.9)111 (29.3)168 (27.2)
3. I can readily determine the available pharmacogenetic tests within our healthcare system.
Agree44 (18.5)71 (18.7)115 (18.6)0.899
Neutral96 (40.3)146 (38.5)242 (39.2)
Disagree98 (41.2)162 (42.7)260 (42.1)
4. I can accurately apply the results of a pharmacogenetic test to drug therapy selection, dosing, or monitoring.
Agree64 (26.9)101 (26.6)165 (26.7)0.973
Neutral97 (40.8)152 (40.1)249 (40.4)
Disagree77 (32.4)126 (33.2)203 (32.9)

*Significant difference between physicians and pharmacists using Chi-square test

Table 5

Influence of respondents’ characteristics on their level of knowledge, perceptions, and self-confidence towards pharmacogenetics (n = 617).

VariableOverall mean (SD) percentage knowledge score (%)P valueOverall mean (SD) Perceptions scoreP valueOverall mean (SD)self-confidence scoreP value
Profession
Pharmacist48.8 (22.7)0.1814.5 (1.7)<0.001*1.1 (1.3)0.082
Physician43.4 (25.4)3.9 (1.9)1.0 (1.3)
Age
≤3544.4 (23.3)0.0734.1 (1.9)0.1851.0 (1.3)0.094
≥3647.8 (25.9)4.3 (1.7)1.1 (1.3)
Gender
Male45.7 (25.9)0.4404.1 (1.8)0.071.0 (1.2)0.061
Female45.7 (22.3)4.3 (1.8)1.1 (1.3)
Work Experience
<1043.6 (23.3)0.002*4.0 (1.9)0.0670.9 (1.3)0.013*
≥1048.0 (25.4)4.3 (1.7)1.1 (1.3)
Attended pharmacogenetics training or education
No45.7 (25)0.9704.1 (1.8)0.016*0.9 (1.2)<0.001*
Yes46.0 (22)4.7 (1.8)2.0 (1.6)
*Significant difference between physicians and pharmacists using Chi-square test *Significant difference between physicians and pharmacists using Chi-square test
  1 in total

1.  Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait.

Authors:  Abdullah Albassam; Shahad Alshammari; Ghadeer Ouda; Samuel Koshy; Abdelmoneim Awad
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.